Summary of WEST PHARMACEUTICAL SERVICES INC

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Compensatory Arrangements of Certain Officers.

At a meeting on July 14, 2009, the compensation committee of the board of directors of West Pharmaceutical Services, Inc. adopted a supplemental long-term incentive plan. The plan provides officers and key employees of the Company an opportunity to receive cash awards based on the achievement of operating-margin improvement targets for the period beginning July 1, 2009 and ending December 31, 2011. The following table shows the estimated cash payouts for each of the executive officers named in the Company's 2009 proxy statement who received awards under the plan.

                                                     Estimated Future Payouts Under Supplemental Long-Term
                                                                        Incentive Plan
                                                      Threshold            Target               Maximum
Name and Title                                           ($)                 ($)                  ($)
Donald E. Morel, Jr.
Chairman of the Board and Chief Executive Officer        225,000             550,000             1,100,000
William J. Federici
Vice President and Chief Financial Officer                75,000             150,000               300,000
Steven A. Ellers
President and Chief Operating Officer                    112,500             225,000               450,000
John R. Gailey III
Vice President, General Counsel and Secretary             37,500              75,000               150,000

All supplemental plan awards will be made under the Company's shareholder-approved 2007 Omnibus Incentive Compensation Plan.